Medtronic buys sinus surgery gel tech
This article was originally published in Clinica
Executive Summary
Medtronic has acquired the rights to an investigational chitosan-dextran gel technology invented in Australia and New Zealand. It plans to develop the product for use during functional endoscopic sinus surgery (FESS) to control bleeding and promote wound healing.